An evaluation of the real world use and clinical utility of the Cxbladder Monitor assay in the follow-up of patients previously treated for bladder cancer

Surveilling recurrent urothelial carcinoma (UC) requires frequent cystoscopy, which is invasive, expensive and time-consuming. An accurate urinary biomarker has the potential to reduce the number of cystoscopi...

Source: BMC Urology - February 11, 2020 Category: Urology & Nephrology Authors: Madhusudan Koya, Sue Osborne, Christophe Chemasl é, Sima Porten, Anne Schuckman and Andrew Kennedy-Smith Tags: Research article Source Type: research